一例侵袭性肺真菌感染合并气管纵隔瘘救治及文献复习
Management of Invasive Pulmonary Fungal Infection Complicated by Tracheobronchial-Mediastinal Fistula: A Case Report and Literature Review
摘要: 目的:探讨侵袭性曲霉合并毛霉感染导致气管–支气管纵隔瘘的临床特征、诊断要点及综合治疗策略。方法:分析1例侵袭性曲霉合并毛霉感染患者的临床资料,包括影像学表现、支气管镜特征、病原学检测结果及治疗过程,并结合相关文献进行分析。结果:患者以咳嗽、咳痰及呼吸困难起病,胸部CT提示肺部感染伴气道结构异常及纵隔内异常气体影;支气管镜检查见气道黏膜广泛坏死,气道壁多处连续性中断,可见多个瘘口,提示气管–支气管纵隔瘘形成,并伴严重气道狭窄。病理及微生物学检查证实曲霉合并毛霉感染。经系统抗真菌治疗联合支气管镜介入(气道支架置入及局部处理)后,肺部炎症一度好转,但气道结构破坏持续存在,支架多次移位。治疗过程中患者出现类似免疫重建炎症反应,经糖皮质激素干预后症状缓解。结论:侵袭性曲霉合并毛霉感染可导致气道壁严重破坏并形成气管–支气管纵隔瘘,是一种少见但危重的临床表现。支气管镜检查在诊断中具有关键作用。治疗需采取系统抗真菌治疗与气道介入相结合的综合策略,并在治疗过程中警惕免疫炎症反应的发生。
Abstract: Objective: To explore the clinical characteristics, diagnostic features, and comprehensive treatment strategies of tracheobronchial mediastinal fistula caused by invasive Aspergillus combined with mucormycosis. Methods: The clinical data of a patient with invasive Aspergillus combined with mucormycosis were retrospectively analyzed, including imaging findings, bronchoscopic features, etiological results, and treatment course, and relevant literature was reviewed. Results: The patient presented with cough, sputum production, and dyspnea. Chest CT showed pulmonary infection with abnormal airway structure and mediastinal gas shadows. Bronchoscopy revealed extensive mucosal necrosis, discontinuity of the airway wall, and multiple fistula openings, suggesting the formation of tracheobronchial mediastinal fistula with severe airway stenosis. Pathological and microbiological examinations confirmed Aspergillus and Mucor co-infection. After systemic antifungal therapy combined with bronchoscopic airway intervention (stent implantation and local treatment), pulmonary inflammation was partially improved; however, airway structural damage persisted and stent displacement occurred repeatedly. During treatment, the patient developed a transient inflammatory exacerbation suggestive of an immune reconstitution-like response, which was alleviated after corticosteroid therapy. Conclusion: Invasive Aspergillus combined with mucormycosis can lead to severe airway destruction and tracheobronchial mediastinal fistula, which is a rare but critical clinical condition. Bronchoscopy plays a key role in diagnosis. Comprehensive treatment combining systemic antifungal therapy and airway intervention is required, and inflammatory reactions during treatment should be closely monitored.
文章引用:杨子艺, 肖玉婷, 李鑫慧, 徐博文, 余西, 孙家兴, 王红梅. 一例侵袭性肺真菌感染合并气管纵隔瘘救治及文献复习[J]. 临床医学进展, 2026, 16(4): 4897-4903. https://doi.org/10.12677/acm.2026.1641763

参考文献

[1] Alqarihi, A., Kontoyiannis, D.P. and Ibrahim, A.S. (2023) Mucormycosis in 2023: An Update on Pathogenesis and Management. Frontiers in Cellular and Infection Microbiology, 13, Article ID: 1254919. [Google Scholar] [CrossRef] [PubMed]
[2] Cornely, O.A., Alastruey-Izquierdo, A., Arenz, D., Chen, S.C.A., Dannaoui, E., Hochhegger, B., et al. (2019) Global Guideline for the Diagnosis and Management of Mucormycosis: An Initiative of the European Confederation of Medical Mycology in Cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infectious Diseases, 19, e405-e21.
[3] Cadena, J., Thompson, G.R. and Patterson, T.F. (2021) Aspergillosis: Epidemiology, Diagnosis, and Treatment. Infectious Disease Clinics of North America, 35, 415-434. [Google Scholar] [CrossRef] [PubMed]
[4] Elkhapery, A., Fatima, M. and Soubani, A.O. (2025) Emerging Risk Factors for Invasive Pulmonary Aspergillosis: A Narrative Review. Journal of Fungi, 11, Article 555. [Google Scholar] [CrossRef] [PubMed]
[5] Hoenigl, M., Seidel, D., Carvalho, A., Rudramurthy, S.M., Arastehfar, A., Gangneux, J., et al. (2022) The Emergence of COVID-19 Associated Mucormycosis: A Review of Cases from 18 Countries. The Lancet Microbe, 3, e543-e552. [Google Scholar] [CrossRef] [PubMed]
[6] Damaraju, V., Agarwal, R., Dhooria, S., Sehgal, I.S., Prasad, K.T., Gupta, K., et al. (2023) Isolated Tracheobronchial Mucormycosis: Report of a Case and Systematic Review of Literature. Mycoses, 66, 5-12. [Google Scholar] [CrossRef] [PubMed]
[7] Kim, M., Lim, J.H., Park, M., Cha, H.K., Kim, L. and Nam, H. (2020) A Rare Case of Fatal Endobronchial Mucormycosis Masquerading as Endobronchial Tuberculosis. Medicina, 56, Article 64. [Google Scholar] [CrossRef] [PubMed]
[8] Wei, L., Zhu, P., Chen, X. and Yu, J. (2022) Mycopathologia, 187, 1-14. [Google Scholar] [CrossRef] [PubMed]
[9] Li, X., Wang, X., Xu, S., Feng, Y., Liu, Y. and Zeng, C. (2025) Invasive Pseudomembranous Aspergillus Tracheobronchitis Accompanied with Fever and Hemoptysis: A Case Report. Clinical Case Reports, 13, e70805. [Google Scholar] [CrossRef] [PubMed]
[10] Sasani, E., Pakdel, F., Khodavaisy, S., Salehi, M., Salami, A., Sohrabi, M., et al. (2024) Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review. Mycopathologia, 189, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
[11] Patel, A., Kaur, H., Xess, I., Michael, J.S., Savio, J., Rudramurthy, S., et al. (2020) A Multicentre Observational Study on the Epidemiology, Risk Factors, Management and Outcomes of Mucormycosis in India. Clinical Microbiology and Infection, 26, 944.e9-944.e15. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, Y., Wang, S., Zhao, H. and Wang, C. (2025) Bronchial Stenosis Requires Vigilance against Tracheal Mucormycosis: A Case Report. Frontiers in Medicine, 12, Article ID: 1510292. [Google Scholar] [CrossRef] [PubMed]
[13] Poursadegh, F., Shazdeh Ahmadi, S., Oskouyan, Z., Alvandi Fard, M.M., Rezaeetalab, F., Mozdorian, M., et al. (2024) A Rare Case of Pulmonary Mucormycosis and Broncho‐Esophageal Fistula in a Patient with Poorly Controlled Diabetes. Clinical Case Reports, 12, e9093. [Google Scholar] [CrossRef] [PubMed]
[14] Fan, Z., Yang, C., Zhang, L., Yang, M., Lv, Y., Xu, S., et al. (2025) Safety and Efficacy of Bronchoscopic Interventions for Tracheobronchial Mucormycosis: A 27-Patient Retrospective Cohort Study. BMC Pulmonary Medicine, 25, Article No. 505. [Google Scholar] [CrossRef
[15] Sayyadi, A., Salajegheh, F., Dalfardi, B. and Shafiepour, M. (2024) Simultaneous Endobronchial and Mediastinal Mucormycosis in a Patient with Diabetes Mellitus and SARS-CoV-2: A Case Report and Literature Review. Heliyon, 10, e34258. [Google Scholar] [CrossRef] [PubMed]
[16] Zheng, Y., Yang, L., Yu, J., Wang, S. and Ye, X. (2025) Invasive Tracheal Mucormycosis Complicated by Myiasis Following Tracheostomy in a Diabetic Patient: A Case Report. Medical Mycology Case Reports, 48, Article 100707. [Google Scholar] [CrossRef] [PubMed]
[17] Mahmood, K., Frazer-Green, L., Gonzalez, A.V., Shofer, S.L., Argento, A.C., Welsby, I., et al. (2025) Management of Central Airway Obstruction: An American College of Chest Physicians Clinical Practice Guideline. CHEST, 167, 283-295. [Google Scholar] [CrossRef] [PubMed]
[18] Sabath, B.F. and Casal, R.F. (2023) Airway Stenting for Central Airway Obstruction: A Review. Mediastinum, 7, Article 18. [Google Scholar] [CrossRef] [PubMed]
[19] Folch, E. and Keyes, C. (2018) Airway Stents. Annals of Cardiothoracic Surgery, 7, 273-283. [Google Scholar] [CrossRef] [PubMed]
[20] Gao, Y., Wang, H., Bai, X.F., Wu, Y., Li, X., Wang, M., et al. (2025) Successful Management of Refractory Pulmonary Mucormycosis Using Intracavitary Amphotericin B: A Case Report and Literature Review. American Journal of Case Reports, 26, e949413. [Google Scholar] [CrossRef
[21] Leng, X., Zhou, H., Xu, Z. and Xu, F. (2024) Oral Isavuconazole Combined with Nebulized Inhalation and Bronchoscopic Administration of Amphotericin B for the Treatment of Pulmonary Mucormycosis: A Case Report and Literature Review. Journal of Fungi, 10, Article 388. [Google Scholar] [CrossRef] [PubMed]
[22] Giacobbe, D.R., Bartalucci, C., Bavastro, M., Schiavoni, R., Di Pilato, V., Muccio, M., et al. (2025) Use of Isavuconazole in Critically Ill Patients in Intensive Care Units: A Prospective, Observational, Multicentre, Cohort Study. Journal of Antimicrobial Chemotherapy Antimicrobial Resistance, 7, dlaf177.
[23] Gunathilaka, S.S., Keragala, R.K., Gunathilaka, K.M., Wickramage, S., Bandara, S.R., Senevirathne, I.S., et al. (2025) Use of Isavuconazole in Mucormycosis: A Systematic Review. BMC Infectious Diseases, 25, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[24] Banz, M., Stallmach, A., Gaßler, N., Schulze, P.C., Fritzenwanger, M., Cornely, O., et al. (2023) Fatal Pulmonary Hemorrhage, Pneumothorax and Skin Necrosis Caused by IRIS to an Aspergillus Flavus Infection in a Young Patient with Metamizole Associated Agranulocytosis. Infection, 52, 685-690. [Google Scholar] [CrossRef] [PubMed]
[25] Chen, Q., Yu, W., Wang, X., Zhao, C., Wang, P., Sun, L., et al. (2024) Case Report: A Diabetic Patient with Cryptococcal Meningoencephalitis Complicated by Post-Infectious Inflammatory Response Syndrome. Frontiers in Immunology, 15, Article ID: 1444486. [Google Scholar] [CrossRef] [PubMed]